Milk Thistle aka Silymarin- Non-conventional therapy for anti-inflammatory, apoptotic, anti-angiogenic, anti-metastatic, anti-oxidant and integrative action- I’ve taken and written about a host
Continue readingMultiple myeloma is defined as smoldering (asymptomatic) or active (symptomatic). The NCCN criteria for smoldering multiple myeloma are as follows The presence of any of the CRAB criteria or any of
Continue reading“multiple myeloma patients aged 70 years or older undergoing autologous stem cell transplantation have better progression-free survival but no difference in OS compared to patients who do not undergo
Continue reading“…this study monitored patients for predictors of CVAEs and found a greater incidence, with 51% of (multiple myeloma treated w/ CFZ) patients experiencing CVAEs, including heart failure, hypertension,
Continue reading“Survival rates vary significantly by stage of the disease. Those with serious cancers (multiple myeloma) who are in stage 1, for example, may have better survival rates than those with stage 2 or
Continue readingDon’t Want to “Watch and Wait?” Reduce Your Risks of Multiple Myeloma, Lose a Few Pounds, Get Healthy and Feel Great- A diagnosis of monoclonal gammopathy of undetermined significance
Continue readingThe challenge for those newly diagnosed Multiple Myeloma patients that achieve remission is that the toxicity of those therapies can cause life-threatening side effects to the patient’s blood, bones,
Continue reading“Plasma cell dyscrasias (MGUS, SMM, MM) are a heterogeneous group of disorders caused by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow. Multiple myeloma is the most
Continue reading“The challenge for multiple myeloma survivors however, is that each proteasome inhibitor will stop working eventually. MDR aka multi-drug resistance is a fact for all multiple myeloma chemotherapy
Continue reading“The study published online today in Blood offers the first evidence that such familial risks exist across the spectrum of hematologic malignancies (MM).” Second only to “Why did I get
Continue reading“For diagnosis of specific toxicities, please see each specific agent or each organ system overview for details. It is important to remember that often the diagnosis of these toxicities is a diagnosis
Continue readingNow we have to wonder how long the lesion (pre-myeloma) will sit there. We can’t pretend they’re not there, but we don’t know what they mean. A single plasmacytoma (SBP), monoclonal gammopathy of
Continue reading